(Q34064633)

30 July 2017

title

An in vivo platform for tumor biomarker assessment (English)

1 reference

30 July 2017

0 references

Valerie W Rusch

7

0 references

Camelia S Sima

5

object named as

Camelia Sima

1 reference

30 July 2017

Elliot L Servais

1

1 reference

30 July 2017

Kei Suzuki

2

1 reference

30 July 2017

Christos Colovos

3

1 reference

30 July 2017

Luis Rodriguez

4

1 reference

30 July 2017

Martin Fleisher

6

1 reference

30 July 2017

Michel Sadelain

8

1 reference

30 July 2017

Prasad S Adusumilli

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

26 October 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

e26722

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

start time

26 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Malignant pleural mesothelioma: an update on biomarkers and treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Translational crossroads for biomarkers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Current status of screening for malignant pleural mesothelioma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202552

Variability in mesothelioma tumor response classification.

28 October 2018

1 reference

12 December 2020

Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose

1 reference

12 December 2020

Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer

1 reference

12 December 2020

Malignant mesothelioma

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0026722

Identifiers

DOI

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference